Peter Doshi, PhD told the FDA the Risks Outweigh Benefits of C-19 Shots for Children

Share this:

On June 10, 2021, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss the current science and data on COVID-19 and the COVID-19 vaccines in pediatric populations, whether giving the shots Emergency Use Authorization (EUA) status for younger kids was justified, or licensing, and if so, when and based on what.

Peter Doshi, PhD told the FDA the clinical trial data showed the risks of the shots are greater than the benefit.


Share this:
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x
Scroll to Top